2m 2m 2m 2m 2m 2m 2m
INMUNE BIO-AI (INMB)
NASDAQ
$2.29-$0.03 (-1.51%)
Price as of Aug 21, 2026 7:31 PM EDT- $64.4MMarket Cap
- -3.73%1-Year Change
- BiotechnologyIndustry
INMUNE BIO-AI (INMB)
$2.29-$0.03 (-1.51%)
INMB | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $2.32 | ||
Change | +$0.16 (+7.41%) | ||
Open | $2.22 | ||
High | $2.34 | ||
Low | $2.19 | ||
Previous Close | $2.16 | ||
Volume | 520,144 | ||
30-Day Average Volume | 341,448 | ||
1-Week Change | 6.91% | ||
1-Month Change | 17.77% | ||
1-Year Change | -3.73% | ||
3-Year Change | -70.37% | ||
5-Year Change | -85.96% | ||
Fundamentals | |||
Shares Outstanding | 27.8M | ||
Total Assets | $26.8M | ||
Market Cap | $64.4M | ||
Enterprise Value | $46.0M | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | -$1.4M | ||
Free Cash Flow | -$3.2M | ||
EBIT | -$1.4M | ||
EBITDA | -$1.3M | ||
Net Working Capital | $17.9M | ||
EPS | -$0.05 | ||
Enterprise Value/EBITDA | -35 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 3 | ||
P/E | -46 | ||
PEG | -1 | ||
Price/Free Cash Flow | -20 | ||
Price/Operating Cash Flow | -20 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue